[1]
|
Eraslan, S., Yıldırım, Ö., Dursun, Ö., Dinç, E., et al. (2020) Relationship between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy. Turkish Journal of Ophthalmology, 50, 163-168. https://doi.org/10.4274/tjo.galenos.2019.91962
|
[2]
|
Stewart, M. (2012) The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology. Mayo Clinic Proceedings, 87, 77-88. https://doi.org/10.1016/j.mayocp.2011.10.001
|
[3]
|
李晓庆, 孟旭霞, 王风磊, 付浴东. 康柏西普对不同OCT分型糖尿病黄斑水肿的治疗效果[J]. 精准医学杂志, 2018, 33(2): 143-146.
|
[4]
|
Chhablani, J., Wong, K., Tan, G., Sudhalkar, A., Laude, A., Cheung, C., et al. (2020) Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines. The Asia-Pacific Journal of Ophthalmology, 9, 426-434. https://doi.org/10.1097/APO.0000000000000312
|
[5]
|
Amoaku, W., Ghanchi, F., Bailey, C., Banerjee, S., Banerjee, S., Downey, L., et al. (2020) Diabetic Retinopathy and Diabetic Macular Oedema Pathways and Management: UK Consensus Working Group. Eye, 34, 1-51.
https://doi.org/10.1038/s41433-020-0961-6
|
[6]
|
Kulikov, A., Sosnovskii, S., Berezin, R., Maltsev, D., Oskanov, D. and Gribanov, N. (2017) Vitreoretinal Interface Abnormalities in Diabetic Macular Edema and Effectiveness of Anti-VEGF Therapy: An Optical Coherence Tomography Study. Clinical Ophthalmology, 11, 1995-2002. https://doi.org/10.2147/OPTH.S146019
|
[7]
|
Duker, J., Kaiser, P., Binder, S., de Smet, M., Gaudric, A., Reichel, E., et al. (2013) The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole. Ophthalmology, 120, 2611-2619. https://doi.org/10.1016/j.ophtha.2013.07.042
|
[8]
|
Farnoodian, M., Wang, S., Dietz, J., Nickells, R., Sorenson, C. and Sheibani, N. (2017) Negative Regulators of Angiogenesis: Important Targets for Treatment of Exudative AMD. Clinical Science, 131, 1763-1780.
https://doi.org/10.1042/CS20170066
|
[9]
|
Alberti, K. and Zimmet, P. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
|
[10]
|
Grant, M., Afzal, A., Spoerri, P., Pan, H., Shaw, L. and Mames, R. (2004) The Role of Growth Factors in the Pathogenesis of Diabetic Retinopathy. Expert Opinion on Investigational Drugs, 13, 1275-1293.
https://doi.org/10.1517/13543784.13.10.1275
|
[11]
|
Liu, E., Craig, J. and Burdon, K. (2017) Diabetic Macular Oedema: Clinical Risk Factors and Emerging Genetic Influences. Clinical and Experimental Optometry, 100, 569-576. https://doi.org/10.1111/cxo.12552
|
[12]
|
Elman, M., Aiello, L., Beck, R., Bressler, N., Bressler, S., Edwards, A., et al. (2010) Randomized Trial Evaluating Ranibizumab plus Prompt or Deferred Laser or Triamcinolone plus Prompt Laser for Diabetic Macular Edema. Ophthalmology, 117, 1064-1077.e35. https://doi.org/10.1016/j.ophtha.2010.02.031
|
[13]
|
Korobelnik, J., Do, D., Schmidt-Erfurth, U., Boyer, D., Holz, F., Heier, J., et al. (2014) Intravitreal Aflibercept for Diabetic Macular Edema. Ophthalmology, 121, 2247-2254. https://doi.org/10.1016/j.ophtha.2014.05.006
|
[14]
|
Brown, D., Schmidt-Erfurth, U., Do, D., Holz, F., Boyer, D., Midena, E., et al. (2015) Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies. Ophthalmology, 122, 2044-2052.
https://doi.org/10.1016/j.ophtha.2015.06.017
|
[15]
|
Boyer, D., Nguyen, Q., Brown, D., Basu, K. and Ehrlich, J. (2015) Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials. Ophthalmology, 122, 2504-2513.e1.
https://doi.org/10.1016/j.ophtha.2015.08.006
|
[16]
|
Li, F., Zhang, L., Wang, Y., Xu, W., Jiao, W., Ma, A., et al. (2018) One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema. Current Eye Research, 43, 218-223. https://doi.org/10.1080/02713683.2017.1379542
|
[17]
|
Sheu, S., Lee, Y., Horng, Y., Lin, H., Lai, W. and Tsen, C. (2018) Characteristics of Diabetic Macular Edema on Optical Coherence Tomography May Change over Time or after Treatment. Clinical Ophthalmology, 12, 1887-1893.
https://doi.org/10.2147/OPTH.S173956
|
[18]
|
Weingessel, B., Miháltz, K., Gleiss, A., Sulzbacher, F., Schütze, C. and Vécsei-Marlovits, P. (2018) Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers. Journal of Ophthalmology, 2018, Article ID: 3082560. https://doi.org/10.1155/2018/3082560
|
[19]
|
李璐希, 姜钊, 陈莲, 李晓清, 张鹏. 康柏西普治疗不同类型糖尿病黄斑水肿的疗效观察[J]. 中华眼底病杂志, 2021, 37(9): 702-708.
|
[20]
|
Gattoussi, S., Cougnard-Grégoire, A., Delyfer, M., Rougier, M., Schweitzer, C., Delcourt, C., et al. (2017) Vitreomacular Adhesion and Its Association with Age-Related Macular Degeneration in a Population-Based Setting: The Alienor Study. Investigative Ophthalmology & Visual Science, 58, 2180-2186. https://doi.org/10.1167/iovs.16-20741
|
[21]
|
Sebag, J. (2015) The Vitreoretinal Interface and Its Role in the Pathogenesis of Vitreomaculopathies. Ophthalmologe, 112, 10-19.
|
[22]
|
Kim, J., You, Y., Kim, S. and Kwon, O. (2017) Epiretinal Membrane Formation after Intravitreal Autologous Stem Cell Implantation in a Retinitis Pigmentosa Patient. Retinal Cases and Brief Reports, 11, 227-231.
https://doi.org/10.1097/ICB.0000000000000327
|
[23]
|
Fung, A., Galvin, J. and Tran, T. (2021) Epiretinal Membrane: A Review. Clinical & Experimental Ophthalmology, 49, 289-308. https://doi.org/10.1111/ceo.13914
|
[24]
|
Mansour, A., Pulido, J. and Arevalo, J. (2015) Diabetic Macular Edema: From Old Concepts to New Therapeutic Avenues. Medical Hypothesis Discovery and Innovation in Ophthalmology, 4, 130-135.
|
[25]
|
Taniguchi, H., Yoshida, I., Sakamoto, M. and Maeno, T. (2021) Epiretinal Membrane Appearance or Progression after Intravitreal Injection in Age-Related Macular Degeneration. BMC Ophthalmology, 21, Article No. 190.
https://doi.org/10.1186/s12886-021-01944-0
|
[26]
|
Klaassen, I., Van Noorden, C. and Schlingemann, R. (2013) Molecular Basis of the Inner Blood-Retinal Barrier and Its Breakdown in Diabetic Macular Edema and Other Pathological Conditions. Progress in Retinal and Eye Research, 34, 19-48. https://doi.org/10.1016/j.preteyeres.2013.02.001
|
[27]
|
夏沁韵, 陈震, 邢怡桥. 玻璃体黄斑界面异常的糖尿病黄斑水肿研究新进展[J]. 武汉大学学报(医学版), 2020, 41(5): 853-856.
|
[28]
|
Namba, R., Kaneko, H., Suzumura, A., Shimizu, H., Kataoka, K., Takayama, K., et al. (2019) In Vitro Epiretinal Membrane Model and Antibody Permeability: Relationship with Anti-VEGF Resistance in Diabetic Macular Edema. Investigative Ophthalmology & Visual Science, 60, 2942-2949. https://doi.org/10.1167/iovs.19-26788
|
[29]
|
张聪, 许贺, 徐丽. 玻璃体切割联合内界膜剥除术治疗顽固性糖尿病黄斑水肿[J]. 国际眼科杂志, 2020, 20(12): 2159-2162.
|
[30]
|
朱丽, 陈晓. 玻璃体切割手术治疗糖尿病黄斑水肿的研究现状与进展[J]. 中华眼底病杂志, 2020, 36(11): 906-909.
|